PulmoBioMed raises £1.4m for innovative lung test commercialization
PulmoBioMed - a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions - has raised £1.4m to help commercialize its technology.
PulmoBioMed - a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions - has raised £1.4m to help commercialize its technology.
The investment round was led by the North... [4929 chars]
Published by: News-Medical.net
Read full article here: https://www.news-medical.net/news/20240212/PulmoBioMed-raises-c2a314m-for-innovative-lung-test-commercialization.aspx
